ARIEL ROEHRICH: Open Payments
NPI 1306576038 · BISMARCK, ND. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$425 in 21 payments from 9 companies in 2025. Trend: 2023 $14 · 2024 $199 · 2025 $425
Food & beverage: $425
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $81 |
| Collegium Pharmaceutical, Inc. | 3 | $64 |
| Neurocrine BioSciences, Inc. | 4 | $63 |
| ABBVIE INC. | 3 | $55 |
| Takeda Pharmaceuticals U.S.A., Inc. | 2 | $46 |
| Novo Nordisk Inc | 2 | $36 |
| Exact Sciences Corporation | 2 | $35 |
| Lilly USA, LLC | 1 | $25 |
| Otsuka America Pharmaceutical, Inc. | 1 | $20 |
Products named: Auvelity, Jornay PM, INGREZZA, TRINTELLIX, Wegovy, The Cologuard Plus Collection Kit, UBRELVY, ZEPBOUND.
Industry payments across ND — which companies pay providers there.
